With help I sent a detailed mail to the MHRA asking why fin remains on the market and calling for its safety to be re evaluated. I’ve since received a full response defending it’s use. I believe there are a number of areas that need further challenge/exploring which weren’t covered. Unfortunately my cognitive skills are continuing to decline effecting my ability to formulate a reply and respond appropriately. I believe this merits effort / pushing forward and could set the ball rolling in making them/ a country reconsider their position re its safety and if not we’d have an audit trail for future action against a public body who failed to consider safety in the face of such evidence. The Thalidomide scandal is a past example.
Considerarive factors/ points for the reply are:-
The Reuters article exposing Merck redacting
Litigation settlement
Very limited study on young men “we need the numbers”
Limited post pharma vigilance
Insufficient potential side list
Under reported sides, cases because of lack of awareness in the medical community
There are probably more areas to raise questions on.
If you can help please drop me a pm and I’ll share the mail trail to date.
Thanks and greatly appreciated.